Pau D'arco for Antimicrobial Properties

Research suggests that Pau d'Arco and its constituent compounds — particularly lapachol, β-lapachone, and α-lapachone — possess notable antimicrobial properties across a range of laboratory and animal studies, with documented activity against bacteria, the malaria parasite, and organisms associated with other infectious conditions. A 2024 laboratory study found that lapachol, when activated by blue LED light, completely eliminated one bacterial strain tested and caused visible structural damage to bacterial cells, pointing to potential applications in addressing antibiotic-resistant infections. Studies indicate that β-lapachone has shown activity in animal models of sepsis, where it appeared to enhance bacterial clearance alongside anti-inflammatory effects, and a 2021 review catalogued its documented activity against tuberculosis bacteria, the parasite responsible for Chagas disease, and malaria. However, the available evidence consists almost entirely of in vitro cell studies, isolated tissue experiments, and animal models rather than human clinical trials, and some compounds such as α- and β-lapachone have shown meaningful toxicity to human cells at effective concentrations, raising questions about therapeutic utility that remain unresolved pending further research.